Best for
Mobile

Posted
Acacia Pharma Group plc (ACPGF) is a leading business based in the US. Acacia Pharma Group is listed on the PINK and employs 37 staff. All prices are listed in US Dollars.
Best for
Mobile
Best for
Low-cost
Best for
All rounder
Best for
Beginners
52-week range | $2.3067 - $4.02 |
---|---|
50-day moving average | $2.9071 |
200-day moving average | $2.9071 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.018 |
Other fees may apply. Your capital is at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -45.3% |
Return on equity TTM | -131.57% |
Profit margin | 0% |
Book value | $0.848 |
Market capitalisation | $329.7 million |
TTM: trailing 12 months
We're not expecting Acacia Pharma Group to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Acacia Pharma Group's shares have ranged in value from as little as $2.3067 up to $4.02. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Acacia Pharma Group's is 2.1054. This would suggest that Acacia Pharma Group's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Subscribe to trending stock alerts for a chance to win
Acacia Pharma Group plc, a hospital pharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the patients undergoing surgery, other invasive procedures, or cancer chemotherapy treatments in the United States and internationally. The company's lead product is BAREMSIS, an intravenous amisulpride for the treatment and prophylaxis of post-operative nausea and vomiting. Its products also comprise APD403, an intravenous and oral amisulpride that has completed Phase II clinical trials for the chemotherapy-induced nausea and vomiting treatment; and BYFAVO, an ultra-short-acting and reversible intravenous benzodiazepine sedative/anesthetic, which has completed Phase III clinical trials for the use in invasive medical procedures, such as colonoscopy and bronchoscopy. The company's products are primarily serves anesthesiologists and oncologists. Acacia Pharma Group plc was founded in 2007 and is based in Cambridge, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.